Schizophrenia: A unique translational opportunity in behavioral neuroendocrinology

Hormones and Behavior

Volumn 50, Issue 4, 2006, Pages 602-611

  Koenig, James I ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Brain; Cognition; Prenatal stress; Rat; Schizophrenia; Social behavior

Indexed keywords

ARTICLE; HEREDITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LABORATORY TEST; MOLECULAR DYNAMICS; NERVE CELL DIFFERENTIATION; NEUROPSYCHIATRY; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; STRESS;

ANIMALS; BRAIN; BRAIN CHEMISTRY; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; PREGNANCY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STRESS; STRESS, PHYSIOLOGICAL;

EID: 33748151933     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2006.06.027     Document Type: Article

References (169)

1. Abi-Dargham A., and Moore H. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9 (2003) 404-416
2. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney Jr. W.E., and Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52 (1995) 258-266
3. Alonso S.J., Navarro E., and Rodriquez M. Permanent dopaminergic alterations in the N. accumbens after prenatal stress. Pharmacol. Biochem. Behav. 49 (1994) 353-358
4. Andreasen N.C., and Carpenter W.T. Diagnosis and classification of schizophrenia. Schiz. Bull. 19 (1993) 199-214
5. Bale T.L., and Dorsa D.M. Regulation of oxytocin receptor messenger ribonucleic acid in the ventromedial hypothalamus by testosterone and its metabolites. Endocrinology 136 (1995) 5135-5138
6. Ballmaier M., Zoli M., Leo G., Agnati L.F., and Spano P. Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal-based model of schizophrenia. Eur. J. Neurosci. 15 (2002) 1197-1205
7. Barbazanges A., Piazza P.V., LeMoal M., and Maccari S. Maternal glucocorticoid secretion mediates long-term effects of prenatal stress. J. Neurosci. 16 (1996) 3943-3949
8. Bayer S.A., Altman J., Russo R.J., and Zhang X. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14 (1993) 83-144
9. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol. Biochem. Behav. 64 (1999) 803-812
10. Becker A., Grecksch G., Bernstein H.G., Hollt V., and Bogerts B. Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis. Psychopharmacology (Berlin) 144 (1999) 333-338
11. Bellack A.S., Schooler N.R., Marder S.R., Kane J.M., Brown C.H., and Yang Y. Do clozapine and risperidone affect social competence and problem solving?. Am. J. Psychiatry 161 (2004) 364-367
12. Benes F.M., and Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25 (2001) 1-27
13. Bernstein H.G., Stanarius A., Baumann B., Henning H., Krell D., Danos P., Falkai P., and Bogerts B. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 83 (1998) 867-875
14. Boksa P. Animal models of obstetric complications in relation to schizophrenia. Brain Res. Brain Res. Rev. 45 (2004) 1-17
15. Borrell J., Vela J.M., Arevalo-Martin A., Molina-Holgado E., and Guaza C. Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26 (2002) 204-215
16. Bowman R.E., MacLusky N.J., Sarmiento Y., Frankfurt M., Gordon M., and Luine V.N. Sexually dimorphic effects of prenatal stress on cognition, hormonal responses, and central neurotransmitters. Endocrinology 145 (2004) 3778-3787
17. Braff D.L., Grillon C., and Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry 49 (1992) 206-215
18. Buchanan R.W., and Carpenter W.T. Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia. J. Nerv. Ment. Dis. 182 (1994) 193-204
19. Buchanan R.W., Breier A., Kirkpatrick B., Ball P., and Carpenter Jr. W.T. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. Am. J. Psychiatry 155 (1998) 751-760
20. Buchanan R.W., Summerfelt A., Tek C., and Gold J. An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia. Schizophr. Res. 59 (2003) 29-33
21. Buchanan R.W., Ball M.P., Weiner E., Kirkpatrick B., Gold J.M., McMahon R.P., and Carpenter Jr. W.T. Olanzapine treatment of residual positive and negative symptoms. Am. J. Psychiatry 162 (2005) 124-129
22. Canuso C.M., Goldstein J.M., and Green A.I. The evaluation of women with schizophrenia. Psychopharmacol. Bull. 34 (1998) 271-277
23. Carboni G., Tueting P., Tremolizzo L., Sugaya I., Davis J., Costa E., and Guidotti A. Enhanced dizocilpine efficacy in heterozygous reeler mice relates to GABA turnover downregulation. Neuropharmacology 46 (2004) 1070-1081
24. Carpenter Jr. W.T., and Buchanan R.W. Schizophrenia. N. Engl. J. Med. 330 (1994) 681-690
25. Carpenter, W.T., Koenig, J.I., submitted for publication. The past, present and future of drug development in schizophrenia: a report to the Institute of Medicine.
26. Carpenter W.T., Kirkpatrick B., and Buchanan R.W. Schizophrenia: syndromes and diseases. J. Psychiatr. Res. 33 (1999) 473-475
27. Chakos M., Lieberman J., Hoffman E., Bradford D., and Sheitman B. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am. J. Psychiatry 158 (2001) 518-526
28. Chrapusta S.J., Egan M.F., Wyatt R.J., Weinberger D.R., and Lipska B.K. Neonatal ventral hippocampal damage modifies serum corticosterone and dopamine release responses to acute footshock in adult Sprague-Dawley rats. Synapse 47 (2003) 270-277
29. Cintra A., Fuxe K., Solfrini V., Agnati L.F., tinner B., Wikstrom A.C., Staines W., Okret S., and Gustafsson J.A. Central peptidergic neurons as targets for glucocorticoid action. Evidence for the presence of glucocorticoid receptor immunoreactivity in various types of classes of peptidergic neurons. J. Steroid Biochem. Mol. Biol. 40 (1991) 93-103
30. Cintra A., Solfrini V., Bunnemann B., Okret S., Bortolotti F., Gustafsson J.A., and Fuxe K. Prenatal development of glucocorticoid receptor gene expression and immunoreactivity in the rat brain and pituitary gland: a combined in situ hybridization and immunocytochemical analysis. Neuroendocrinology 57 (1993) 1133-1147
31. Coe C.L., Kramer M., Czeh B., Gould E., Reeves A.J., Kirschbaum C., and Fuchs E. Prenatal stress diminishes neurogenesis in the dentate gyrus of juvenile rhesus monkeys. Biol. Psychiatry 54 (2003) 1025-1034
32. Costa E., Davis J., Grayson D.R., Guidotti A., Pappas G.D., and Pesold C. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol. Dis. 8 (2001) 723-742
33. Costa E., Davis J., Pesold C., Tueting P., and Guidotti A. The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics. Curr. Opin. Pharmacol. 2 (2002) 56-62
34. Costa E., Chen Y., Davis J., Dong E., Noh J.S., Tremolizzo L., Veldic M., Grayson D.R., and Guidotti A. REELIN and schizophrenia: a disease at the interface of the genome and the epigenome. Mol. Interv. 2 (2002) 47-57
35. Cyr M., Calon F., Morissette M., and Di Paolo T. Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. J. Psychiatry Neurosci. 27 (2002) 12-27
36. de Kloet E.R., Sibug R.M., Helmerhorst F.M., and Schmidt M. Stress, genes and the mechanism of programming the brain for later life. Neurosci. Biobehav. Rev. 29 (2005) 271-281
37. Dean B. Signal transmission, rather than reception, is the underlying neurochemical abnormality in schizophrenia. Aust. N. Z. J. Psychiatry 34 (2000) 560-569
38. Ellenbroek B.A., van Luijtelaar G., Frenken M., and Cools A.R. Sensory gating in rats: lack of correlation between auditory evoked potential gating and prepulse inhibition. Schizophr. Bull. 25 (1999) 777-788
39. Elmer G.I., Sydnor J., Guard H., Hercher E., and Vogel M.W. Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: an animal model for sensorimotor gating deficits in schizophrenia. Psychopharmacology (Berlin) 174 (2004) 177-189
40. File S.E. Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour. Neuropsychobiology 13 (1985) 55-62
41. File S.E., and Hyde J.R. A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants. Pharmacol. Biochem. Behav. 11 (1979) 65-69
42. Fink G., Sumner B.E., Rosie R., Grace O., and Quinn J.P. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell. Mol. Neurobiol. 16 (1996) 325-344
43. First M.B., Frances A., and Pincus H.A. DSM-IV-TR. Handbook of Differential Diagnosis (2002), American Psychiatric Association Publishing
44. Flagstad P., Glenthoj B.Y., and Didriksen M. Cognitive deficits caused by late gestational disruption of neurogenesis in rats: a preclinical model of schizophrenia. Neuropsychopharmacology 30 (2005) 250-260
45. Fortier M.E., Joober R., Luheshi G.N., and Boksa P. Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J. Psychiatr. Res. 38 (2004) 335-345
46. Freedman R. Schizophrenia. N. Engl. J. Med. 349 (2003) 1738-1749
47. Freedman R., Hall M., Adler L.E., and Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychiatry 38 (1995) 22-33
48. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., and Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 587-592
49. Freedman R., Adams C.E., and Leonard S. The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia. J. Chem. Neuroanat. 20 (2000) 299-306
50. Fride E., and Weinstock M. Prenatal stress increases anxiety related behavior and alters cerebral lateralization of dopamine activity. Life Sci. 42 (1988) 1059-1065
51. Fride E., and Weinstock M. Alterations in behavioral and striatal dopamine asymmetries induced by prenatal stress. Pharmacol. Biochem. Behav. 32 (1989) 425-430
52. Fride E., Dan Y., Feldon J., Halevy G., and Weinstock M. Effects of prenatal stress on vulnerability to stress on prepubertal and adult rats. Physiol. Behav. 37 (1986) 681-687
53. Friedman J.I., Temporini H., and Davis K.L. Pharmacologic strategies for augmenting cognitive performance in schizophrenia. Biol. Psychiatry 45 (1999) 1-16
54. Fujioka T., Sakata Y., Yamaguchi K., Shibasaki T., Kato H., and Nakamura S. The effects of prenatal stress on the development of hypothalamic paraventricular neurons in fetal rats. Neuroscience 92 (1999) 1079-1088
55. Gerardin D.C., Pereira O.C., Kempinas W.G., Florio J.C., Moreira E.G., and Bernardi M.M. Sexual behavior, neuroendocrine, and neurochemical aspects in male rats exposed prenatally to stress. Physiol. Behav. 84 (2005) 97-104
56. Gilmore J.H., Fredrik Jarskog L., Vadlamudi S., and Lauder J.M. Prenatal infection and risk for schizophrenia: IL-1beta, IL-6, and TNFalpha inhibit cortical neuron dendrite development. Neuropsychopharmacology 29 (2004) 1221-1229
57. Goff D.C., and Wine L. Glutamate in schizophrenia: clinical and research implications. Schizophr. Res. 27 (1997) 157-168
58. Goff D.C., Tsai G., Levitt J., Amico E., and Monoach D.S. A placebo-controlled trial of d-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch. Gen. Psychiatry 56 (1999) 21-27
59. Goldman M.B., Blake L., Marks R.C., Hedeker D.R., and Luchins D.J. Association of nonsuppression of cortisol on the DST with primary polydipsia in chronic schizophrenia. Am. J. Psychiatry 150 (1993) 653-655
60. Goldstein J.M. Sex, hormones and affective arousal circuitry dysfunction in schizophrenia. Horm. Behav. (2006) (this issue). doi:10.1016/j.yhbeh.2006.06.029
61. Goldstein J.M., Seidman L.J., Horton N.J., Makris N., Kennedy D.N., Caviness Jr. V.S., Faraone S.V., and Tsuang M.T. Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cereb. Cortex 11 (2001) 490-497
62. Goldstein J.M., Seidman L.J., O'Brien L.M., Horton N.J., Kennedy D.N., Makris N., Caviness Jr. V.S., Faraone S.V., and Tsuang M.T. Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Arch. Gen. Psychiatry 59 (2002) 154-164
63. Griffin III W.C., Skinner H.D., Salm A.K., and Birkle D.L. Mild prenatal stress in rats is associated with enhanced conditioned fear. Physiol. Behav. 79 (2003) 209-215
64. Gur R.E., Turetsky B.I., Cowell P.E., Finkelman C., Maany V., Grossman R.I., Arnold S.E., Bilker W.B., and Gur R.C. Temporolimbic volume reductions in schizophrenia. Arch. Gen. Psychiatry 57 (2000) 769-775
65. Gur R.E., Kohler C., Turetsky B.I., Siegel S.J., Kanes S.J., Bilker W.B., Brennan A.R., and Gur R.C. A sexually dimorphic ratio of orbitofrontal to amygdala volume is altered in schizophrenia. Biol. Psychiatry 55 (2004) 512-517
66. Hafner H. Gender differences in schizophrenia. Psychoneuroendocrinology 28 Suppl. 2 (2003) 17-54
67. Halbreich U., and Kahn L.S. Hormonal aspects of schizophrenias: an overview. Psychoneuroendocrinology 28 Suppl. 2 (2003) 1-16
68. Halim N.D., Weickert C.S., McClintock B.W., Hyde T.M., Weinberger D.R., Kleinman J.E., and Lipska B.K. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Mol. Psychiatry 8 (2003) 797-810
69. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122 Pt. 4 (1999) 593-624
70. Harrison P.J. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berlin) 174 (2004) 151-162
71. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 (2004) 40-68
72. Heckers S., and Konradi C. Hippocampal neurons in schizophrenia. J. Neural Transm. 109 (2002) 891-905
73. Hemby S.E., Ginsberg S.D., Brunk B., Arnold S.E., Trojanowski J.Q., and Eberwine J.H. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch. Gen. Psychiatry 59 (2002) 631-640
74. Henry C., Kabbaj M., Simon H., LeMoal M., and Maccari S. Prenatal stress increases the hypothalamo-pituitary-adrenal axis response in young and adult rats. J. Neuroendocrinol. 6 (1994) 341-345
75. Henry C., Guegant G., Cador M., Arnauld E., Arsaut J., LeMoal M., and Demotes-Mainard J. Prenatal stress in rats facilitates amphetamine-induced sensitization and induces long-lasting changes in dopamine receptors in the nucleus accumbens. Brain Res. 685 (1995) 179-186
76. Herman J.P., Cullinan W.E., Morano M.I., Akil H., Watson J., and S.J. Contribution of the ventral subiculum to inhibitory regulation of the hypothalamic-pituitary-adrenocortical axis. J. Neuroendocrinol. 7 (1995) 475-482
77. Herman J.P., Dolgas C.M., and Carlson S.L. Ventral subiculum regulates hypothalamo-pituitary-adrenocortical and behavioral responses to cognitive stressors. Neuroscience 86 (1998) 449-459
78. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., and Cullinan W.E. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front. Neuroendocrinol. 24 (2003) 151-180
79. Houy E., Raux G., Thibaut F., Belmont A., Demily C., Allio G., Haouzir S., Fouldrin G., Petit M., Frebourg T., and Campion D. The promoter - 194 C polymorphism of the nicotinic alpha 7 receptor gene has a protective effect against the P50 sensory gating deficit. Mol. Psychiatry 9 (2004) 320-322
80. Howes O.D., McDonald C., Cannon M., Arseneault L., Boydell J., and Murray R.M. Pathways to schizophrenia: the impact of environmental factors. Int. J. Neuropsychopharmacol. 7 Suppl. 1 (2004) S7-S13
81. Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., Uzonov D.P., Smalheiser N.R., Davis J.M., Pandey G.N., Pappas G.D., Tueting P., Sharma R.P., and Costa E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15718-15723
82. Jansen L.M., Gispen-de Wied C.C., and Kahn R.S. Selective impairments in the stress response in schizophrenic patients. Psychopharmacology (Berlin) 149 (2000) 319-325
83. Jentsch J.D., and Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20 (1999) 201-225
84. Kinnunen A.K., Koenig J.I., and Bilbe G. Repeated variable prenatal stress alters pre- and postsynaptic gene expression in the rat frontal pole. J. Neurochem. 86 (2003) 736-748
85. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., and Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol. Psychiatry 9 544 (2004) 609-620
86. Koenig, J.I., 2005. Hippocampal-dependent cognitive function and nicotinic receptor expression is compromised by prenatal stress exposure in the rat. Abstr.-Soc. Neurosci. 35, 556.515.
87. Koenig J.I., Kirkpatrick B., and Lee P. Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 27 (2002) 309-318
88. Koenig J.I., Elmer G.I., Shepard P.D., Lee P.R., Mayo C., Joy B., Hercher E., and Brady D.L. Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behav. Brain Res. 156 (2005) 251-261
89. Konradi C. Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis. Brain Res. Brain Res. Rev. 50 (2005) 142-155
90. Kosfeld M., Heinrichs M., Zak P.J., Fischbacher U., and Fehr E. Oxytocin increases trust in humans. Nature 435 (2005) 673-676
91. Lammers C.H., Garcia-Borreguero D., Schmider J., Gotthardt U., Dettling M., Holsboer F., and Heuser I.J. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls. II. Biol. Psychiatry 38 (1995) 803-807
92. Laruelle M., Abi-Dargham A., van Dyck C.H., Gil R., D'Souza C.D., Erdos J., McCance E., Rosenblatt W., Fingado C., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Krystal J.H., Charney D.S., and Innis R.B. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9235-9240
93. Laruelle M., Abi-Dargham A., Gil R., Kegeles L., and Innis R. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol. Psychiatry 46 (1999) 56-72
94. Lavin A., Moore H.M., and Grace A.A. Prenatal disruption of neocortical development alters prefrontal cortical neuron responses to dopamine in adult rats. Neuropsychopharmacology 30 (2005) 1426-1435
95. Le Pen G., and Moreau J.L. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology 27 (2002) 1-11
96. Lee P.R., and Koenig J.I. Social deficits in animal models of schizophrenia are reversed by oxytocin. Soc. Neurosci. (2004) 34
97. Lee, P.R., Brady, D., Shapiro, R.A., Dorsa, D.M., Koenig, J.I., 2003. Schizophrenia-related developmental insults alter social behaviors and neuropeptides in adult rats. Abstr.-Soc. Neurosci. 33, #754.714.
98. Lee P.R., Brady D., Shapiro R.A., Dorsa D.M., and Koenig J.I. Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology 30 (2005) 1883-1894 (published online 1882/1816/1805)
99. Lehmann J.M., Stohr T., and Feldon J. Long-term effects of prenatal stress experience and postnatal maternal separation on emotionality and attentional processes. Beh. Brain Res. 107 (2000) 133-144
100. Lemaire V., Koehl M., Le Moal M., and Abrous D.N. Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 11032-11037
101. Levin E.D. Nicotinic receptor subtypes and cognitive function. J. Neurobiol. 53 (2002) 633-640
102. Levin E.D., McClernon F.J., and Rezvani A.H. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berlin) 184 (2006) 523-539
103. Lewis D.A., and Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 25 (2002) 409-432
104. Lewis D.A., Pierri J.N., Volk D.W., Melchitzky D.S., and Woo T.U. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol. Psychiatry 46 (1999) 616-626
105. Lipska B.K. Using animal models to test a neurodevelopmental hypothesis of schizophrenia. J. Psychiatry Neurosci. 29 (2004) 282-286
106. Lipska B.K., and Weinberger D.R. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 23 (2000) 223-239
107. Lipska B.K., Lerman D.N., Khaing Z.Z., Weickert C.S., and Weinberger D.R. Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs. Eur. J. Neurosci. 18 (2003) 391-402
108. Liu W., Pappas G.D., and Carter C.S. Oxytocin receptors in brain cortical regions are reduced in haploinsufficient (+/-) reeler mice. Neurol. Res. 27 (2005) 339-345
109. McCarthy M.M. Estrogen modulation of oxytocin and its relation to behavior. Adv. Exp. Med. Biol. 395 (1995) 235-245
110. McClure W.O., Ishtoyan A., and Lyon M. Very mild stress of pregnant rats reduces volume and cell number in nucleus accumbens of adult offspring: some parallels to schizophrenia. Brain Res. Dev. Brain Res. 149 (2004) 21-28
111. McCormick C.M., Smythe J.W., Sharma S., and Meaney M.J. Sex-specific effects of prenatal stress on hypothalamic-pituitary-adrenal responses to stress and brain glucocorticoid receptor density in adult rats. Dev. Brain Res. 84 (1995) 55-61
112. McEwen B.S. Neuroendocrine interactions. Psychopharmacology: The Fourth Generation of Progress (1995), Raven Press, New York, NY 705-718
113. McEwen B.S., Angulo J., Cameron H., Chao H.M., Daniels D., Gannon M.N., Gould E., Mendelson S., Sakai R., Spencer R., and Woolley C. Paradoxical effects of adrenal steroids on the brain: protection versus degeneration. Biol. Psychiatry 31 (1992) 177-199
114. Meyer U., Feldon J., Schedlowski M., and Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci. Biobehav. Rev. 29 (2005) 913-947
115. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., and Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28 (2000) 53-67
116. Mirnics K., Middleton F.A., Lewis D.A., and Levitt P. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci. 24 (2001) 479-486
117. Newcomer J.W., Faustman W.O., Whiteford H.A., Moses Jr. J.A., and Csernansky J.G. Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients. Biol. Psychiatry 29 (1991) 855-864
118. Nierop A., Bratsikas A., Klinkenberg A., Nater U.M., Zimmermann R., and Ehlert U. Prolonged salivary cortisol recovery in second-trimester pregnant women and attenuated salivary {alpha}-amylase responses to psychosocial stress in human pregnancy. J. Clin. Endocrinol. Metab. 91 (2006) 1329-1335
119. Owen M.J., Williams N.M., and O'Donovan M.C. The molecular genetics of schizophrenia: new findings promise new insights. Mol. Psychiatry 9 (2004) 14-27
120. Palmer A.A., Printz D.J., Butler P.D., Dulawa S.C., and Printz M.P. Prenatal protein deprivation in rats induces changes in prepulse inhibition and NMDA receptor binding. Brain Res. 996 (2004) 193-201
121. Pongrac J., Middleton F.A., Lewis D.A., Levitt P., and Mirnics K. Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochem. Res. 27 (2002) 1049-1063
122. Rapoport J.L., Addington A.M., Frangou S., and Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry 10 (2005) 434-449
123. Rehn A.E., Van Den Buuse M., Copolov D., Briscoe T., Lambert G., and Rees S. An animal model of chronic placental insufficiency: relevance to neurodevelopmental disorders including schizophrenia. Neuroscience 129 (2004) 381-391
124. Richardson H.N., Zorrilla E.P., Mandyam C.D., and Rivier C.L. Exposure to repetitive versus varied stress during prenatal development generates two distinct anxiogenic and neuroendocrine profiles in adulthood. Endocrinology 147 (2006) 2506-2517
125. Riecher-Rossler A., Hafner H., Stumbaum M., Maurer K., and Schmidt R. Can estradiol modulate schizophrenic symptomatology?. Schiz. Bull. 20 (1994) 203-214
126. Rimondini R., Agren G., Borjesson S., Sommer W., and Heilig M. Persistent behavioral and autonomic supersensitivity to stress following prenatal stress exposure in rats. Behav. Brain Res. 140 (2003) 75-80
127. Salm A.K., Pavelko M., Krouse E.M., Webster W., Kraszpulski M., and Birkle D.L. Lateral amygdaloid nucleus expansion in adult rats is associated with exposure to prenatal stress. Brain Res. Dev. Brain Res. 148 (2004) 159-167
128. Sams-Dodd F. Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats. Behav. Pharmacol. 6 (1995) 55-65
129. Sams-Dodd F. A test of the predictive validity of animal models of schizophrenia based on phencyclidine and d-amphetamine. Neuropsychopharmacology 18 (1998) 293-304
130. Sams-Dodd F., Lipska B.K., and Weinberger D.R. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology (Berlin) 132 (1997) 303-310
131. Sapolsky R.M., Romero L.M., and Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21 (2000) 55-89
132. Sawada K., Barr A.M., Nakamura M., Arima K., Young C.E., Dwork A.J., Falkai P., Phillips A.G., and Honer W.G. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch. Gen. Psychiatry 62 (2005) 263-272
133. Schmitz C., Rhodes M.E., Bludau M., Kaplan S., Ong P., Ueffing I., Vehoff J., Korr H., and Frye C.A. Depression: reduced number of granule cells in the hippocampus of female, but not male, rats due to prenatal restraint stress. Mol. Psychiatry 7 (2002) 810-813
134. Seeman M.V. The role of estrogen in schizophrenia. J. Psychiatry Neurosci. 21 (1996) 123-127
135. Seeman M.V. Women and schizophrenia. Medscape Women's Health 5 (2000) 2
136. Selemon L.D. Regionally diverse cortical pathology in schizophrenia: clues to the etiology of the disease. Schizophr. Bull. 27 (2001) 349-377
137. Selemon L.D., and Goldman-Rakic P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 45 (1999) 17-25
138. Selemon L.D., and Rajkowska G. Cellular pathology in the dorsolateral prefrontal cortex distinguishes schizophrenia from bipolar disorder. Curr. Mol. Med. 3 (2003) 427-436
139. Stevens K.E., Kem W.R., Mahnir V.M., and Freedman R. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology (Berlin) 136 (1998) 320-327
140. Stryjer R., Strous R.D., Bar F., Werber E., Shaked G., Buhiri Y., Kotler M., Weizman A., and Rabey J.M. Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia. Clin. Neuropharmacol. 26 (2003) 12-17
141. Sullivan P.F. The genetics of schizophrenia. PLoS Med. 2 (2005) e212
142. Swerdlow N.R., and Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schiz. Bull. 24 (1998) 285-301
143. Swerdlow N.R., Lipska B.K., Weinberger D.R., Braff D.L., Jaskiw G.E., and Geyer M.A. Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology (Berlin) 122 (1995) 27-34
144. Swerdlow N.R., Braff D.L., and Geyer M.A. Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav. Pharmacol. 11 (2000) 185-204
145. Swerdlow N.R., Geyer M.A., and Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156 (2001) 194-215
146. Szuran T.F., Pliska V., Pokorny J., and Welzl H. Prenatal stress in rats: effects on plasma corticosterone, hippocampal glucocorticoid receptors, and maze performance. Physiol. Behav. 71 (2000) 353-362
147. Takahashi L.K., Baker E.W., and Kalin N.H. Ontogeny of behavioral and hormonal responses to stress in prenatally stressed male rat pups. Physiol. Behav. 47 (1990) 357-364
148. Takahashi L.K., Haglin C., and Kalin N.H. Prenatal stress potentiates stress-induced behavior and reduces the propensity to play in juvenile rats. Physiol. Behav. 51 (1992) 319-323
149. Takahashi L.K., Turner J.G., and Kalin N.H. Prolonged stress-induced elevation in plasma corticosterone during pregnancy in the rat: implications for prenatal stress studies. Psychoneuroendocrinology 23 (1998) 571-581
150. Tamminga C.A. Schizophrenia and glutamatergic transmission. Crit. Rev. Neurobiol. 12 (1998) 21-36
151. Thompson T.L., and Moss R.L. Estrogen regulation of dopamine release in the nucleus accumbens: genomic- and nongenomic-mediated effects. J. Neurochem. 62 (1994) 1750-1756
152. Tsai G., and Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 165-179
153. Walder D.J., Walker E.F., and Lewine R.J. Cognitive functioning, cortisol release and symptom severity in patients with schizophrenia. Biol. Psychiatry 48 (2000) 1121-1132
154. Walker E.F., Diforio D., and Baum K. Developmental neuropathology and the precursors of schizophrenia. Acta Psychiatr. Scand., Suppl. 395 (1999) 12-19
155. Wan R.Q., and Corbett R. Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions. Neuropsychopharmacology 16 (1997) 259-268
156. Wan R.Q., Giovanni A., Kafka S.H., and Corbett R. Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies. Behav. Brain Res. 78 (1996) 211-223
157. Ward I.L., and Weisz J. Differential effects of maternal stress on circulating levels of corticosterone, progesterone, and testosterone in male and female rat fetuses and their mothers. Endocrinology 114 (1984) 1635-1644
158. Ward H.E., Johnson E.A., Salm A.K., and Birkle D.L. Effects of prenatal stress on defensive withdrawal behavior and corticotropin releasing factor systems in rat brain. Physiol. Behav. 70 (2000) 359-366
159. Watts A.G. Glucocorticoid regulation of peptide genes in neuroendocrine CRH neurons: a complexity beyond negative feedback. Front. Neuroendocrinol. 26 (2005) 109-130
160. Webster M.J., Knable M.B., O'Grady J., Orthmann J., and Weickert C.S. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol. Psychiatry 7 924 (2002) 985-994
161. Weinstein D.D., Diforio D., Schiffman J., Walker E., and Bonsall R. Minor physical anomalies, dermatoglyphic asymmetries, and cortisol levels in adolescents with schizotypal personality disorder. Am. J. Psychiatry 156 (1999) 617-623
162. Weinstock M. Alterations induced by gestational stress in brain morphology and behavior of the offspring. Prog. Neurobiol. 65 (2001) 427-451
163. Welberg L.A., Thrivikraman K.V., and Plotsky P.M. Chronic maternal stress inhibits the capacity to up-regulate placental 11beta-hydroxysteroid dehydrogenase type 2 activity. J. Endocrinol. 186 (2005) R7-R12
164. White D.A., and Birkle D.L. The differential effects of prenatal stress in rats on the acoustic startle reflex under baseline conditions and in response to anxiogenic drugs. Psychopharmacology (Berlin) 154 (2001) 169-176
165. Wu E.Q., Birnbaum H.G., Shi L., Ball D.E., Kessler R.C., Moulis M., and Aggarwal J. The economic burden of schizophrenia in the United States in 2002. J. Clin. Psychiatry 66 (2005) 1122-1129
166. Xing G.Q., Russell S., Webster M.J., and Post R.M. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder. Int. J. Neuropsychopharmacol. 7 (2004) 143-153
167. Zak P.J., Kurzban R., and Matzner W.T. Oxytocin is associated with human trustworthiness. Horm. Behav. 48 (2005) 522-527
168. Zarrow M.X., Philpott J.E., and Denenberg V.H. Passage of 14C-4-corticosterone from the rat mother to the foetus and neonate. Nature 226 (1970) 1058-1059
169. Zuckerman L., and Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J. Psychiatr. Res. 39 (2005) 311-323